drugset / Trial / NCT06685705

Comparative Study Between Intrathecal Magnesium Sulfate, Neostigmine and Fentanyl as Adjuvant for Bubivacaine in Postoperative Analgesia in Lower Abdominal Surgeries

NCT06685705

Phase 4 Not yet recruiting 66 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

Lower abdominal surgeries often result in severe pain, which in turn can cause rapid and shallow breathing, retention of secretions and poor patient compliance. Justifiably, apart from the fear for the surgery outcome, patients are concerned mainly with postoperative pain. If treated inadequately, acute pain can have serious consequences for patient health mainly with postoperative complications, prolonged recovery and increased length of hospital stay. Higher levels of postoperative pain and pain distress are associated with increased morbidity, poorer functional recovery, and reduced quality of life. Aim of the study To compare the duration, quality of analgesia, and side effects between intrathecal Magnesium sulfate, neostigmine and fentanyl as adjuvant for bubivacaine as postoperative analgesia in lower abdominal surgeries

Timeline

Start
2024-12-01
Primary completion
2025-12-01
Completion
2026-01-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 25 ug Intrathecal
Subject Magnesium Sulfate Other / unclassified 50 mg Intrathecal
Subject Neostigmine Other / unclassified 50 ug Intrathecal
Background Bupivacaine Other / unclassified 15 mg Intrathecal

Indications

No indication recorded.